Mereo BioPharma's Loss Stretches In 2019 But Pleased With Progress
Mereo BioPharma's Loss Stretches In 2019 But Pleased With Progress
Read moreMereo BioPharma's Loss Stretches In 2019 But Pleased With Progress
Read moreMereo Shares Surge As It Completes USD70 Million US Fundraise
Read moreEXECUTIVE CHANGE SUMMARY: Medica Poaches CFO From Mereo BioPharma
Read moreMereo BioPharma Expects No Setrusumab Trial Delays Despite Covid-19
Read moreMereo BioPharma Says US Regulator Meeting For Setrusumab "Successful"
Read moreMereo BioPharma Secures USD3 Million Investment From Unnamed US Firm
Read more(Sharecast News) - Mereo BioPharma Group has entered into a securities purchase agreement with a new US-based institutional healthcare investor, it announced on Wednesday.
Read moreMereo Secures Novartis Fundraising Amid More Backing From US Investors
Read moreMereo BioPharma Reports Additional Positive Data From Setrusumab Study
Read moreMereo BioPharma Could Net USD300 Million From Navicixizumab Deal
Read moreWoodford Transfers Series Of Holdings To New Manager Schroders
Read moreMereo Gets Positive Setrusumab Trial Results; Plans Pediatric Studies
Read morePRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford
Read moreDIRECTOR DEALINGS: Mereo BioPharma Chair Buys GBP15,000 In Shares
Read moreMereo BioPharma Drug Navicixizumab Gets Fast Track Designation In US
Read more